With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.
Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.
Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment.
Brain tumours are heavily influenced by their surroundings so understanding the environment they’re in could reveal ways to destroy them.
Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides.
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.